Cyberonics (Nasdaq: CYBX) reported earnings on June 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended April 27 (Q4), Cyberonics beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share increased significantly.

Margins increased across the board.

Revenue details
Cyberonics notched revenue of $57.6 million. The eight analysts polled by S&P Capital IQ foresaw revenue of $56.5 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $51.1 million.

My

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.39. The eight earnings estimates compiled by S&P Capital IQ predicted $0.35 per share. GAAP EPS of $0.38 for Q4 were 46% higher than the prior-year quarter's $0.26 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 92.2%, 430 basis points better than the prior-year quarter. Operating margin was 31.2%, 570 basis points better than the prior-year quarter. Net margin was 18.5%, 400 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $58.2 million. On the bottom line, the average EPS estimate is $0.36.

Next year's average estimate for revenue is $243.1 million. The average EPS estimate is $1.55.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 124 members out of 157 rating the stock outperform, and 33 members rating it underperform. Among 46 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give Cyberonics a green thumbs-up, and 14 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cyberonics is outperform, with an average price target of $41.86.

The healthcare investing landscape is littered with also-rans and a few major winners. Is Cyberonics the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.